SLC35G1 (extracellular) Blocking Peptide (#BLP-NT196) is the original antigen used for immunization during Anti-SLC35G1 (extracellular) Antibody (#ANT-196) generation. The blocking peptide binds and ‘blocks’ Anti-SLC35G1 (extracellular) primary antibody, this makes it a good negative reagent control to help confirm antibody specificity in western blot and immunohistochemistry applications. This control is also often called a pre-adsorption control.
- Western blot analysis of rat brain membrane (lanes 1 and 3) and mouse brain membrane (lanes 2 and 4):
- Western blot analysis of rat heart (lanes 5 and 7) and mouse heart (lanes 6 and 8) lysates:
- Western blot analysis of human chronic myelogenous leukemia MEG-O1 cell line (lanes 9 and 10) lysates:
- C)SDTSGMEESYSGHLK, corresponding to amino acid residues 209-223 of human SLC35G1 (Accession Q2M3R5).